These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 9200945)
1. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression]. Matsui M Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945 [TBL] [Abstract][Full Text] [Related]
2. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298 [TBL] [Abstract][Full Text] [Related]
3. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases. Fowler E; Weiner HL Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395 [TBL] [Abstract][Full Text] [Related]
4. Oral tolerance for the treatment of autoimmune diseases. Weiner HL Annu Rev Med; 1997; 48():341-51. PubMed ID: 9046967 [TBL] [Abstract][Full Text] [Related]
6. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Weiner HL Microbes Infect; 2001 Sep; 3(11):947-54. PubMed ID: 11564443 [TBL] [Abstract][Full Text] [Related]
7. [Collagen in the treatment of rheumatic diseases--oral tolerance]. Stancikova M; Stancik R; Gubzova Z; Rovensky J Bratisl Lek Listy; 1999; 100(10):567-71. PubMed ID: 10649854 [TBL] [Abstract][Full Text] [Related]
8. Oral tolerance for treating uveitis - new hope for an old immunological mechanism. Thurau SR; Wildner G Prog Retin Eye Res; 2002 Nov; 21(6):577-89. PubMed ID: 12433378 [TBL] [Abstract][Full Text] [Related]
9. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026 [TBL] [Abstract][Full Text] [Related]
13. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. Friedman A; al-Sabbagh A; Santos LM; Fishman-Lobell J; Polanski M; Das MP; Khoury SJ; Weiner HL Chem Immunol; 1994; 58():259-90. PubMed ID: 8011155 [TBL] [Abstract][Full Text] [Related]
14. Oral tolerance: mechanisms and therapy of autoimmune diseases. Koh DR Ann Acad Med Singap; 1998 Jan; 27(1):47-53. PubMed ID: 9588275 [TBL] [Abstract][Full Text] [Related]
15. Oral tolerance and the treatment of rheumatoid arthritis. Weiner HL; Komagata Y Springer Semin Immunopathol; 1998; 20(1-2):289-308. PubMed ID: 9836383 [No Abstract] [Full Text] [Related]
16. Immunomodulation of experimental autoimmune diseases via oral tolerance. Krause I; Blank M; Shoenfeld Y Crit Rev Immunol; 2000; 20(1):1-16. PubMed ID: 10770268 [TBL] [Abstract][Full Text] [Related]
17. Oral tolerance in the control of experimental models of autoimmune disease. Staines NA; Harper N Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685 [TBL] [Abstract][Full Text] [Related]
18. Oral tolerance in the treatment of rheumatoid arthritis. Toussirot EA Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):45-52. PubMed ID: 14561205 [TBL] [Abstract][Full Text] [Related]
19. Oral tolerance in the treatment of inflammatory autoimmune diseases. Wardrop RM; Whitacre CC Inflamm Res; 1999 Mar; 48(3):106-19. PubMed ID: 10219652 [TBL] [Abstract][Full Text] [Related]
20. Oral tolerance. Weiner HL; da Cunha AP; Quintana F; Wu H Immunol Rev; 2011 May; 241(1):241-59. PubMed ID: 21488901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]